تولید آنتی بادی اختصاصی سرطان به عنوان یک نانو داروی هدفمند

Nanomedicines have been considered as advanced tools for medical and chemotherapy treatments. Nanomedicines have found wide application in the treatment of various diseases, including cancer, due to their unique properties, including nanoscale size, broad spectrum of biological activity, and precise targeting ability. In this invention, a nanomedicine product with the ability to control the release of hypochlorous acid at the tumor site is presented as an advanced and novel technique for the treatment of lung cancer. The present nanomedicine formulation is capable of transporting and releasing hypochlorous acid at the precise location of the tumor. It also has the ability to precisely control the amount and time of hypochlorous acid release to optimize the therapeutic effect and reduce damage to healthy tissues. Considering that lung cancer is one of the most common and deadly types of cancer, a nanomedicine product with the ability to control the release of hypochlorous acid can be an efficient and advanced therapeutic tool to improve the treatment outcomes and quality of life of patients with lung cancer. Nanomedicines have been considered as advanced tools for medical and chemotherapy treatments. Nanomedicines have found wide application in the treatment of various diseases, including cancer, due to their unique properties, including nanoscale size, broad spectrum of biological activity, and precise targeting ability. In this invention, a nanomedicine product with the ability to control the release of hypochlorous acid at the tumor site is presented as an advanced and novel technique for the treatment of lung cancer. The present nanomedicine formulation is capable of transporting and releasing hypochlorous acid at the precise location of the tumor. It also has the ability to precisely control the amount and time of hypochlorous acid release to optimize the therapeutic effect and reduce damage to healthy tissues. Considering that lung cancer is one of the most common and deadly types of cancer, a nanomedicine product with the ability to control the release of hypochlorous acid can be an efficient and advanced therapeutic tool to improve the treatment outcomes and quality of life of patients with lung cancer.